A dose-ranging study of MF59(®)-adjuvanted and non-adjuvanted A/H1N1 pandemic influenza vaccine in young to middle-aged and older adult populations to assess safety, immunogenicity...

Por Reisinger, Keith S, Holmes, Sandra J, Pedotti, Paola, Arora, Ashwani Kumar, Lattanzi, Maria
Publicado no Hum Vaccin Immunother (2014)

Safety and immunogenicity of meningococcal ACWY CRM(197)-conjugate vaccine in children, adolescents and adults in Russia

Por Ilyina, Natalia, Kharit, Susanna, Namazova-Baranova, Leila, Asatryan, Asmik, Benashvili, Mayya, Tkhostova, Elmira, Bhusal, Chiranjiwi, Arora, Ashwani Kumar
Publicado no Hum Vaccin Immunother (2014)

Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for children

Por Knuf, Markus, Leroux-Roels, Geert, Rümke, Hans, Rivera, Luis, Pedotti, Paola, Arora, Ashwani Kumar, Lattanzi, Maria, Kieninger, Dorothee, Cioppa, Giovanni Della
Publicado no Hum Vaccin Immunother (2015)

Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscu...

Por Mahendra, BJ, Narayana, DH Ashwath, Agarkhedkar, Sharad, Ravish, HS, Harish, BR, Agarkhedkar, Shalaka, Madhusudana, SN, Belludi, Ashwin, Ahmed, Khaleel, Jonnalagedda, Rekha, Vakil, Hoshang, Bhusal, Chiranjiwi, Arora, Ashwani Kumar
Publicado no Hum Vaccin Immunother (2015)